Philip Morris Cuts Growth Forecast Despite Strong Zyn Performance
Philip Morris lowers 2025 operating income growth estimate to 10-11.5% due to heavy US investments in Zyn nicotine pouches, despite strong sales and raised earnings forecast.
Markets move fast. You should move faster. Be the first to know when deals break, stocks move, or biotech headlines hit. Sign up to get breaking news alerts the moment they happen.
Philip Morris lowers 2025 operating income growth estimate to 10-11.5% due to heavy US investments in Zyn nicotine pouches, despite strong sales and raised earnings forecast.
JPMorgan raises Carvana stock target to $490 with Overweight rating, citing strong operational advantages and dismissing consumer credit concerns ahead of Q3 earnings.
Warner Bros. Discovery expands strategic review after receiving "multiple" buyout offers. Stock jumps 8% as company considers sale alongside planned split into two businesses.
GE Aerospace raises 2025 profit forecast twice in four months as jet engine demand surges, maintenance revenue jumps 33%, and supply chain improvements drive 41% delivery increase.
Coca-Cola's Q3 results exceed Wall Street forecasts with 6% organic revenue growth, driven by zero-sugar drinks, smaller packages, and strategic pricing across global markets.
RTX Corp. beats Q3 earnings expectations and raises 2025 profit forecast to $6.10-$6.20 per share, driven by strong aerospace demand and defense sales despite tariff challenges.